<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Eli Lilly Begins Phase III Clinical Trial for Coronavirus
Image Overlay - Eli Lilly Begins Phase III Clinical Trial for Coronavirus

Eli Lilly Begins Phase III Clinical Trial for Coronavirus

June 24, 2020

Eli Lilly Begins Phase III Clinical Trial for Coronavirus

The company has begun phase III clinical trials for Olumiant, which is an approved treatment for rheumatoid arthritis. The company will enroll 400 patients in the U.S., Europe, and Latin America in the trial for the potential coronavirus treatment. With depots across Latin America and Europe and headquarters in the U.S., Yourway is equipped to service global clinical trials.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat
Come chat with us!
Hello! How can I help you?